Stimulating Innovation Management of Polypharmacy and Adherence in the Elderly

Dear Healthcare Stakeholder

Polymedication and poor adherence to therapy are major burdens to ageing societies in Europe. These are priority issues in management of chronic diseases and to promote good health in Europe. Your support in developing the effective and sustainable health services of the future is of major importance to us.

As I am sure you are aware, safe and effective pharmacotherapy remains one of the greatest challenges in medicine where models of healthcare delivery lag behind the enormous growth in single disease focused pharmacotherapy. The implications for sale, efficient and effective deployment of healthcare resources and sustainability are significant from both healthcare and societal perspectives.

The SIMPATHY project aims to stimulate, promote and support innovation across the EU in the management of appropriate polypharmacy and adherence in the elderly, in order to contribute to efficient and sustainable healthcare systems. 

Through a programme of work and stakeholder engagement we will perform case studies in a range of different healthcare environments, including European Innovation Partnership – Active Healthy Ageing reference sites, providing a framework and politico-economic basis for an EU wide benchmarking survey of strategies being employed for polypharmacy and non-adherence management, which we hope you may be interested in participating in.

The results of our work will be shared with stakeholders like yourself to support policy development, implementation of strategic organisational development and exchange of best practice to prepare the ground for necessary change in response to this major challenge.

We propose to contact you again to invite your participation in our study, in the meantime I have attached a flyer to provide an overview of the project which I hope you will find of interest and you may wish to share with colleagues or contacts. Further information is also available at our website (www.simpathy.eu) and you can follow discussions on Twitter @simpathyproject. I very much hope you will find our work of interest and be able to get involved.

Alpana Mair – Coordinator

This comunication is part of the SIMPATHY project (663082) which has received funding from the European Union’s Health Programme (2014-2020)